Overview
Xq12-q13.3 duplication syndrome is a very rare genetic condition caused by having an extra copy of a specific region on the X chromosome, between positions Xq12 and Xq13.3. This duplication means that certain genes in this region are present in more copies than usual, which can disrupt normal development. The condition primarily affects males more severely than females, since males have only one X chromosome and the extra genetic material has a greater impact. People with this syndrome typically show developmental delays, intellectual disability, and various physical features that may be noticeable from early childhood. Common findings can include low muscle tone (hypotonia), feeding difficulties in infancy, speech and language delays, and distinctive facial features. Some individuals may also experience seizures or behavioral challenges. The severity of symptoms can vary depending on the exact size of the duplication and which genes are involved. There is currently no cure for Xq12-q13.3 duplication syndrome. Treatment focuses on managing individual symptoms and supporting development. This may include speech therapy, physical therapy, occupational therapy, and special education services. Seizures, if present, are managed with anti-seizure medications. Early intervention programs can help children reach their full developmental potential. A team of specialists typically works together to provide comprehensive care tailored to each person's needs.
Also known as:
Key symptoms:
Intellectual disabilityDelayed speech and language developmentLow muscle tone (floppiness)Feeding difficulties in infancyDistinctive facial featuresDelayed motor milestones like sitting and walkingSeizures or epilepsyBehavioral difficultiesLearning disabilitiesPoor coordinationGrowth delaysGenital abnormalities in males
Clinical phenotype terms (37)— hover any for plain English
X-linked dominant
Carried on the X chromosome; a single copy can cause the condition
Infantile
Begins in infancy, roughly 1 month to 2 years old
Treatments
No FDA-approved treatments are currently listed for Xq12-q13.3 duplication syndrome.
View clinical trials →Clinical Trials
View all trials with filters →No actively recruiting trials found for Xq12-q13.3 duplication syndrome at this time.
New trials open frequently. Follow this disease to get notified.
Specialists
View all specialists →No specialists are currently listed for Xq12-q13.3 duplication syndrome.
Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Travel Grants
No travel grants are currently matched to Xq12-q13.3 duplication syndrome.
Community
No community posts yet. Be the first to share your experience with Xq12-q13.3 duplication syndrome.
Start the conversation →Latest news about Xq12-q13.3 duplication syndrome
No recent news articles for Xq12-q13.3 duplication syndrome.
Follow this condition to be notified when news becomes available.
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Questions for your doctor
Bring these to your next appointment
- Q1.What is the exact size and location of my child's duplication, and which genes are involved?,How might this specific duplication affect my child's development over time?,What therapies should we start right away, and how often should they occur?,Should we be screening for seizures or other medical complications?,Is there a risk that other family members carry this duplication?,What educational supports should we request for my child at school?,Are there any research studies or registries we should consider joining?
Common questions about Xq12-q13.3 duplication syndrome
What is Xq12-q13.3 duplication syndrome?
Xq12-q13.3 duplication syndrome is a very rare genetic condition caused by having an extra copy of a specific region on the X chromosome, between positions Xq12 and Xq13.3. This duplication means that certain genes in this region are present in more copies than usual, which can disrupt normal development. The condition primarily affects males more severely than females, since males have only one X chromosome and the extra genetic material has a greater impact. People with this syndrome typically show developmental delays, intellectual disability, and various physical features that may be noti
How is Xq12-q13.3 duplication syndrome inherited?
Xq12-q13.3 duplication syndrome follows a x-linked dominant inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.
At what age does Xq12-q13.3 duplication syndrome typically begin?
Typical onset of Xq12-q13.3 duplication syndrome is infantile. Age of onset can vary across affected individuals.